Pacifica Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.7K Sell
310
-18
-5% -$2.37K 0.01% 201
2026
Q1
$45.7K Hold
328
0.02% 201
2025
Q4
$39.9K Hold
328
0.02% 192
2025
Q3
$36.5K Buy
328
+73
+29% +$8.3K 0.01% 226
2025
Q2
$28.2K Hold
255
0.01% 240
2025
Q1
$28.7K Hold
255
0.01% 230
2024
Q4
$23.4K Hold
255
0.01% 264
2024
Q3
$21.4K Hold
255
0.01% 291
2024
Q2
$17K Sell
255
-70
-22% -$4.67K 0.01% 316
2024
Q1
$23.6K Hold
325
0.01% 284
2023
Q4
$25.7K Sell
325
-29
-8% -$2.26K 0.01% 278
2023
Q3
$26.4K Sell
354
-130
-27% -$10K 0.01% 253
2023
Q2
$37.4K Hold
484
0.02% 190
2023
Q1
$40.2K Hold
484
0.02% 190
2022
Q4
$41.2K Buy
484
+70
+17% +$5.54K 0.03% 169
2022
Q3
$26K Buy
414
+266
+180% +$16.8K 0.02% 208
2022
Q2
$9K Hold
148
0.01% 312
2022
Q1
$9K Hold
148
0.01% 313
2021
Q4
$11K Hold
148
0.01% 293
2021
Q3
$11K Sell
148
-122
-45% -$8.57K 0.01% 288
2021
Q2
$18K Hold
270
0.01% 217
2021
Q1
$18K Buy
270
+122
+82% +$7.87K 0.01% 210
2020
Q4
$9K Hold
148
0.01% 257
2020
Q3
$9K Hold
148
0.01% 219
2020
Q2
$11K Sell
148
-30
-17% -$2.3K 0.01% 219
2020
Q1
$13K Buy
178
+105
+144% +$7.25K 0.02% 207
2019
Q4
$5K Buy
+73
New +$4.75K ﹤0.01% 287

Other funds holding GILD

Pacifica Partners's GILD Position: Q2 2026 in Review

Pacifica Partners reduced its Gilead Sciences (GILD) stake by 5.5% in Q2 2026, selling an estimated $2.37K and leaving 310 shares worth $40.7K. The position accounts for 0.01% of the portfolio, ranked #201.

Pacifica Partners first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $45.7K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pacifica Partners held 310 shares of Gilead Sciences worth $40.7K as of Q2 2026.
  • Pacifica Partners sold 18 Gilead Sciences shares in Q2 2026, an estimated $2.37K.
  • Gilead Sciences made up 0.01% of Pacifica Partners's portfolio in Q2 2026, its #201 holding.
  • Pacifica Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Pacifica Partners's Gilead Sciences position peaked at $45.7K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.